Showing results (701-710 of 6,765) with videos related to

Sort By:
Pageof 677
Clinical Therapeutics|September 16, 1998
Weight-based heparin dosing: clinical response and resource utilizationC L Lackie, A B Luzier, J A Donovan, et al.
Clinical Therapeutics|September 16, 1998
Predictors of medication adherence in the elderlyR Balkrishnan
Clinical Therapeutics|September 16, 1998
Economic consequences of selective serotonin reuptake inhibitor use with drugs also metabolized by the cytochrome P-450 systemR J Ozminkowski, T R Hylan, C A Melfi, et al.
Clinical Therapeutics|September 16, 1998
Selective serotonin reuptake inhibitor utilization patterns: consistency across research designsD S Hutchins, E G Klein, W F Signa, et al.
Clinical Therapeutics|September 16, 1998
The cost of treating community-acquired pneumoniaM S Niederman, J S McCombs, A N Unger, et al.
Clinical Therapeutics|July 15, 1998
An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Irbesartan/Losartan Study InvestigatorsS Oparil, R Guthrie, A J Lewin, et al.
Clinical Therapeutics|July 15, 1998
Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study GroupD Silvers, M Kipnes, V Broadstone, et al.
Clinical Therapeutics|July 15, 1998
A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatientsF W Reimherr, L A Cunningham, S R Batey, et al.
Clinical Therapeutics|July 15, 1998
Cost comparisons between nafarelin and leuprolide in the treatment of endometriosisS Z Zhao, L M Arguelles, J M Wong, et al.
Clinical Therapeutics|October 4, 2012
Long-term efficacy and safety profile of rilonacept in the treatment of cryopryin-associated periodic syndromes: results of a 72-week open-label extension studyHal M Hoffman, Martin L Throne, Niran J Amar, et al.
Pageof 677